The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mHtt containing expanded polyglutamine (polyQ) tracts increases p53 levels and transcriptional activity in neuronal cells by binding to p53.251”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [251]
In the citing paper
“Affected brain regions in HD patients, HD animal models, and cells overexpressing mHtt present elevated p53 levels.251,255”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [251]
In the citing paper
“inhibition of p53 activity with a small-molecule antagonist of p53, pifithrin-α, or by genetic ablation effectively diminished many of the symptoms in models of these p53-dependent diseases”
From p53 at a glance (2010) · cites this paper as Bae et al., 2005
In the citing paper
“Furthermore, in several neurological disorders, including Alzheimer's, Parkinson's and Huntington's diseases, p53-mediated neuronal apoptosis also contributes to the associated pathologies (Bae et al., 2005; Bretaud et al., 2007; Culmsee and Mattson, 2005; Duan et al., 2002).”
From p53 at a glance (2010) · cites this paper as Bae et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 8×
“Because nuclear p53 regulates many mitochondrial genes and genes for oxidative stress (Sharpless and DePinho, 2002; Vogelstein et al., 2000), we hypothesized that p53 might link the nuclear and mitochondrial pathologies in HD.”
BackgroundInfluentialMice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 1×
“The increased p53 occurs selectively in the P1 fractions designated as crude nuclei (Figure 1A) in 1% SDS-soluble, nonaggregate fractions (Figure 1C), implying that the transactivation-independent role for p53 in the mitochondria is unlikely (Chipuk et al., 2004).”
BackgroundDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
Saudou, F., Finkbeiner, S., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,595
PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells
Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., & Vogelstein, B. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00213-1 · Cited by 1,280
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Nucifora, F. C., Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V. L., et al. (2001) · Science · doi:10.1126/science.1056784 · Cited by 1,094
Self-citationExpression of baculovirus P35 prevents cell death in Drosophila
Hay, B. A., Wolff, T., & Rubin, G. M. (1994) · Development · doi:10.1242/dev.120.8.2121 · Cited by 1,066
Steffan, J. S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.-Z., Gohler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,062
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Beal, M., Brouillet, E., Jenkins, B., Ferrante, R., Kowall, N., Miller, J., Storey, E., Srivastava, R., Rosen, B., & Hyman, B. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,027
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
(2000) · Cited by 919
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Jiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852
Hodgson, J. G., Agopyan, N., Gutekunst, C.-A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 830
Schilling, G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.397 · Cited by 753
Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease
Dunah, A. W., Jeong, H., Griffin, A., Kim, Y.-M., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., & Krainc, D. (2002) · Science · doi:10.1126/science.1072613 · Cited by 708
Experimental models of Parkinson's disease
Beal, M. F. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072550 · Cited by 637
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
Trettel, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2799 · Cited by 610
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Sawa, A., Wiegand, G. W., Cooper, J., Margolis, R. L., Sharp, A. H., Lawler, J. F., Greenamyre, J. T., Snyder, S. H., & Ross, C. A. (1999) · Nature Medicine · doi:10.1038/13518 · Cited by 552
Self-citationJackson, G. R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P. W., MacDonald, M. E., & Zipursky, S. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80573-5 · Cited by 533
Failure of the ubiquitin-proteasome system in Parkinson’s disease
McNaught, K. S. P., Olanow, C. W., Halliwell, B., Isacson, O., & Jenner, P. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086067 · Cited by 519
Ross, C. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00872-3 · Cited by 507
Self-citationPivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
Sánchez, I., Mahlke, C., & Yuan, J. (2003) · Nature · doi:10.1038/nature01301 · Cited by 503
Wheeler, V. C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.503 · Cited by 469
Swerdlow, N. R., Paulsen, J., Braff, D. L., Butters, N., Geyer, M. A., & Swenson, M. R. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.2.192 · Cited by 441
Reddy, P. H., Williams, M., Charles, V., Garrett, L., Pike-Buchanan, L., Whetsell, W. O., Miller, G., & Tagle, D. A. (1998) · Nature Genetics · doi:10.1038/2510 · Cited by 399
Kim, Y. J., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K. B., Qin, Z.-H., Aronin, N., & DiFiglia, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221451398 · Cited by 398
Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S., Kimura, T., Koide, R., Nozaki, K., Sano, Y., et al. (2000) · Nature Genetics · doi:10.1038/79139 · Cited by 393
Loss of the p53 tumor suppressor gene protects neurons from kainate- induced cell death
Morrison, R., Wenzel, H., Kinoshita, Y., Robbins, C., Donehower, L., & Schwartzkroin, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-04-01337.1996 · Cited by 375
Cooper, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.783 · Cited by 375
Wellington, C. L., Singaraja, R., Ellerby, L., Savill, J., Roy, S., Leavitt, B., Cattaneo, E., Hackam, A., Sharp, A., Thornberry, N., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001475200 · Cited by 358
Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse
Tabrizi, S. J., Workman, J., Hart, P. E., Mangiarini, L., Mahal, A., Bates, G., Cooper, J. M., & Schapira, A. H. V. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1<80::aid-ana13>3.0.co;2-k · Cited by 351
Interaction of Huntington Disease Protein with Transcriptional Activator Sp1
Li, S.-H., Cheng, A. L., Zhou, H., Lam, S., Rao, M., Li, H., & Li, X.-J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1277-1287.2002 · Cited by 340
Direct Interactions between HIF-1α and Mdm2 Modulate p53 Function
Chen, D., Li, M., Luo, J., & Gu, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200694200 · Cited by 334
Calpain Activation in Huntington's Disease
Gafni, J., & Ellerby, L. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04842.2002 · Cited by 331
The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity
Hackam, A. S., Singaraja, R., Wellington, C. L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M., & Hayden, M. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.5.1097 · Cited by 313
Targeted mutagenesis by homologous recombination in D. melanogaster
Rong, Y. S., Titen, S. W., Xie, H. B., Golic, M. M., Bastiani, M., Bandyopadhyay, P., Olivera, B. M., Brodsky, M., Rubin, G. M., & Golic, K. G. (2002) · Genes & Development · doi:10.1101/gad.986602 · Cited by 310
Marsh, J. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.13 · Cited by 263
Nuclear Inclusions in Glutamine Repeat Disorders
Sisodia, S. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81743-2 · Cited by 259
Sharpless, N. E., & DePinho, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00818-8 · Cited by 250
Huntington's disease: the challenge for cell biologists
Tobin, A. J., & Signer, E. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01853-5 · Cited by 229
Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses
Sipione, S., Rigamonti, D., Valenza, M., Zuccato, C., Conti, L., Pritchard, J., Kooperberg, C., Olson, J. M., & Cattaneo, E. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu539 · Cited by 223
Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses
Sipione, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1953 · Cited by 209
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
Duan, W., Zhu, X., Ladenheim, B., Yu, Q., Guo, Z., Oyler, J., Cutler, R. G., Cadet, J. L., Greig, N. H., & Mattson, M. P. (2002) · Annals of Neurology · doi:10.1002/ana.10350 · Cited by 204
Nuclear Targeting of Mutant Huntingtin Increases Toxicity
Peters, M. F., Nucifora, F. C., Kushi, J., Seaman, H. C., Cooper, J. K., Herring, W. J., Dawson, V. L., Dawson, T. M., & Ross, C. A. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0773 · Cited by 191
Self-citationThe role of p53 in neuronal cell death
Morrison, R. S., & Kinoshita, Y. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400741 · Cited by 174
p53 Expression Induces Apoptosis in Hippocampal Pyramidal Neuron Cultures
Jordán, J., Galindo, M. F., Prehn, J. H. M., Weichselbaum, R. R., Beckett, M., Ghadge, G. D., Roos, R. P., Leiden, J. M., & Miller, R. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01397.1997 · Cited by 167
Hansson, O., Guatteo, E., Mercuri, N. B., Bernardi, G., Li, X., Castilho, R. F., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01767.x · Cited by 153
Significantly lower incidence of cancer among patients with Huntington disease
S�rensen, S. A., Fenger, K., & Olsen, J. H. (1999) · Cancer · Cited by 130
de Aguilar, J. G., Gordon, J. W., René, F., de Tapia, M., Lutz‐Bucher, B., Gaiddon, C., & Loeffler, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0295 · Cited by 123
Bioenergetics in Huntington's Disease
Grünewald, T., & Beal, M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07827.x · Cited by 114
A lysosomal tetraspanin associated with retinal degeneration identified via a genome‐wide screen
Xu, H., Lee, S., Suzuki, E., Dugan, K. D., Stoddard, A., Li, H.-S., Chodosh, L. A., & Montell, C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600112 · Cited by 112
Self-citationSchilling, G., Savonenko, A. V., Klevytska, A. M., Morton, J. L., Tucker, S. M., Poirier, M. A., Gale, A., Chan, N., Gonzales, V., Slunt, H. H., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh175 · Cited by 107
Self-citationA novel in vivo post‐translational modification of p53 by PARP‐1 in MPTP‐induced parkinsonism
Mandir, A. S., Simbulan-Rosenthal, C. M., Poitras, M. F., Lumpkin, J. R., Dawson, V. L., Smulson, M. E., & Dawson, T. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01144.x · Cited by 92
Inducible PC12 cell model of Huntington’s disease shows toxicity and decreased histone acetylation
Igarashi, S., Morita, H., Bennett, K. M., Tanaka, Y., Engelender, S., Peters, M. F., Cooper, J. K., Wood, J. D., Sawa, A., & Ross, C. A. (2003) · Neuroreport · doi:10.1097/00001756-200303240-00007 · Cited by 72
Self-citationSuppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1
Kazemi‐Esfarjani, P., & Benzer, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2657 · Cited by 72
Sang, T., Li, C., Liu, W., Rodríguez, A., Abrams, J., Zipursky, S. L., & Jackson, G. R. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi032 · Cited by 57
Absence of p53: No Effect in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis
Kuntz, C., Kinoshita, Y., Beal, M. F., Donehower, L. A., & Morrison, R. S. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7464 · Cited by 49
Sawa, A. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100223 · Cited by 49
Self-citationReduction of Purkinje Cell Pathology in SCA1 Transgenic Mice by p53 Deletion
Shahbazian, M. D., Orr, H. T., & Zoghbi, H. Y. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0444 · Cited by 39
Mitochondrial function in Huntington's disease: Clues for pathogenesis and prospects for treatment
Schapira, A. H. V. (1997) · Annals of Neurology · doi:10.1002/ana.410410203 · Cited by 27
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Cited by
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Walker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,603
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
Mitochondria in neuroplasticity and neurological disorders
Mattson, M. P., Gleichmann, M., & Cheng, A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.010 · Cited by 1,081
Metadata
- Authors
- Bae, B.-I., Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., Hayward, S. D., Moran, T. H., Montell, C., Ross, C. A., Snyder, S. H., & Sawa, A.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 47
- Issue
- 1
- Pages
- 29-41
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2061258627
- Cited by
- 485
- References
- 72
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.